Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD

Masafumi Ikeda; Tatsuya Yamashita; Sadahisa Ogasawara; Masatoshi Kudo; Yoshitaka Inaba; Manabu Morimoto; Kaoru Tsuchiya; Satoshi Shimizu; Yasushi Kojima; Atsushi Hiraoka; Kazuhiro Nouso; Hiroshi Aikata; Kazushi Numata; Tosiya Sato; Takuji Okusaka; Junji Furuse

doi:10.1159/000531820

Shared by

Masatoshi Kudo

Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD

Article 2023 en

Authors

MI
Masafumi Ikeda
TY
Tatsuya Yamashita
SO
Sadahisa Ogasawara

Abstract

1 min read

Lenvatinib plus HAIC with cisplatin yielded a favorable ORR and overall survival and was well tolerated in patients with advanced HCC. Further evaluation of this regimen in a phase III trial is warranted.

Related publications

Dataset

Supplementary Material for: Multicenter Phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD

Masafumi Ikeda, Tatsuya Yamashita, Sadahisa Ogasawara, Masatoshi Kudo, Yoshitaka Inaba, Manabu Morimoto, Kaoru Tsuchiya, Shinichi Shimizu, Yasushi Kojima, Atsushi Hiraoka, Kazuhiro Nouso, Hiroshi Aikata, Kazushi Numata, Tosiya Sato, Takuji Okusaka, Junji Furuse

Article2015

Sorafenib plus intra-arterial cisplatin versus sorafenib alone in patients with advanced hepatocellular carcinoma: A randomized phase II trial.

Masafumi Ikeda, Satoshi Shimizu, Tosiya Sato, Manabu Morimoto, Yoshitaka Inaba, Yasushi Kojima, Atsushi Hagihara, Masatoshi Kudo, Shoji Nakamori, Shuichi Kaneko, Rie Sugimoto, Toshiyuki Tahara, Takumi Ohmura, Kohichiroh Yasui, Keiko Sato, Hiroshi Ishii, Junji Furuse, Takuji Okusaka

Article2015

Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil

Kazuomi Ueshima, Masatoshi Kudo, Masatoshi Tanaka, Takashi Kumada, Hobyung Chung, Satoru Hagiwara, Tatsuo Inoue, Norihisa Yada, Satoshi Kitai

Dataset

Supplementary Material for: Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma

Kazuomi Ueshima, Sadahisa Ogasawara, Masafumi Ikeda, Y. Yasui, Takeshi Terashima, T. Yamashita, Shuntaro Obi, Shunsuke Sato, Hiroshi Aikata, Takumi Ohmura, Hidekatsu Kuroda, Takamasa Ohki, Kazutaka Nagashima, Yoshihiko Ooka, Mashiro Takita, Mami Kurosaki, Kazuaki Chayama, Shuichi Kaneko, Namiki Izumi, Naoya Kato, Masatoshi Kudo, Masao Omata

Article2021

937P Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD

Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD

Abstract

Discussion(0)

Related publications

Supplementary Material for: Multicenter Phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD

Sorafenib plus intra-arterial cisplatin versus sorafenib alone in patients with advanced hepatocellular carcinoma: A randomized phase II trial.

Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil

Supplementary Material for: Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma

937P Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD